NIDEK presents Optical Coherence Tomography RS-3000 Advance
- July 25, 2012, Gamagori, JAPAN -
NIDEK CO., LTD., a global leader in the design, manufacturing, and distribution of ophthalmic equipment, is pleased to introduce the RS-3000 Advance. This premier OCT system incorporating Scanning Laser Ophthalmoscope is designed for comprehensive evaluation of the retina and choroid. The RS-3000 Advance provides exquisite detail of the retinal and choroidal microstructures to assist in clinical diagnosis.
Features include the choroidal mode, which allows detailed evaluation of the choroid. The ultrafine, fine, and regular measurement sensitivities of the RS-3000 Advance can be selected according to the pathology under assessment. A wide area scan of 9 mm x 9 mm ensures excellent overall coverage of the retinal structures. Corresponding normative databases for glaucoma and the macula augment clinical efficiency. The unique Eye Tracer technology allows accurate measurements utilizing fundus information obtained from the high definition SLO image. The Eye Tracer technology incorporates positioning, tracing, and auto-shot functions, which facilitate fast and easy measurements. Microsaccades and other involuntary eye movements are compensated by the Tracing HD function during the macular line scans. This function ensures accurate alignment of up to 120 macular line scan images for enhanced image averaging. Follow-up images are accurately aligned with the baseline data for high reproducibility. The automatic registration function compensates for cyclotorsion during image acquisition enhancing the quality of follow-up data.
NIDEK will showcase the RS-3000 Advance at EURETINA / ESCRS 2012 in Milan.
During EURETINA / ESCRS 2012, NIDEK will host a EURETINA lunch symposium on retinal imaging diagnosis and laser treatment. For further information, please visit:
For further information contact:
Public Relations, Planning Dept.
NIDEK CO., LTD.
NOTE: The availability of the products differs from country to country depending on the status of regulatory approval in each country. Specifications and design are subject to change.